Levels of indoxyl sulfate are associated with severity of coronary atherosclerosis Abstract Purpose: Indoxyl sulfate (IS) is linked to endothelial damage, NF-κB activation and induced development of atherosclerosis. e purpose of this study was to investigate the relationship between serum IS levels and the severity of coronary artery stenosis. In addition, the relationship among IS and various cardiovascular risk factors was also explored.
Chronic kidney disease (CKD), which closely correlates with high cardio-vascular disease (CVD) prevalence and mortality, has been a clinical challenge for a long time. ere are several common pathogenetic pathways between CKD and coronary artery disease (CAD) and mounting data supports the lethal synergy in CKD patients with CVD [1] . CKD is simply a staging parameter referring to kidney function, whereas the process of vascular damage is the consequence of mediators such as the uremic toxins that are retained as kidney function deterioration; these are the compounds that provide direct toxic e ects, causing coronary artery injury [2, 3] .
Protein-bound uremic retention solutes constitute a group whose common characteristic is their di cult removal by dialysis. Many of these compounds, which accumulate in patients with CKD, have the capacity to interfere with metabolic systems in the body, leading to cardio-vascular damage [4] . Previous studies also show that uremic retention solutes play a role in in ammation and are implicated in the pathogenesis of accelerated atherosclerosis [5, 6] . Indoxyl sulphate (IS), a proteinbound uremic retention solute, is one of the organic anions metabolized in the liver from indole, which is produced by intestinal bacteria as a metabolite of tryptophan [7] . Dou et al. demonstrated that IS and p-cresol suppress both wound repair and the proliferation of endothelial cells (ECs) that are derived from the human umbilical vein [8] . IS also enhances the production of reactive oxygen species (ROS), increases NAD(P)H oxidase activity and decreases glutathione levels in these cells [9] . Yamamoto et al. [10] showed that IS causes vascular smooth muscle cells (VSMCs) to proliferate via activation of extracellular-regulated protein kinase (ERK). Motojima et al. [11] showed that IS induces plasminogen activator inhibitor-1 (PAI-1) and activates nuclear factor-kappaB (NF-kB) in human renal proximal tubular cells. In addition, our previous study demonstrated that serum IS levels were elevated in patients with type 2 diabetes and CAD. is increase was associated with renal function deterioration, in ammation and coronary atherosclerosis [12] .
Because the pathogenesis of atherosclerosis involves the dysfunction of vascular ECs, proliferation of VSMCs [13] [14] [15] and activation of NF-kB [11] , which, in turn, up-regulates PAI-1 expression [16] , these ndings indicate that IS induces the initiation and/or progression of atherosclerosis. Although such evidence of the biological toxicity of IS support its possible role as a cardiovascular risk factor, there is paucity of data on the association between IS levels and the severity or extent of CAD. In the present study, which is aimed at investigating this hypothesis, serum IS levels and angiographic indexes of the number of diseased vessels, calcium scores, and modi ed Gensini score (as measured by cardiac multi-slice computed tomography) were assessed in a cohort of stable angina patients. e possible association between IS levels and selected cardiovascular risk factors were also examined in this patient population.
Methods

Study population
e study population consisted of 191 consecutive patients who underwent rst-time angiography with clinical diagnosis as suspected stable angina from June 2007 to June 2009 at the Cardiovascular Clinic of E-Da Hospital. Stable angina pectoris was de ned as e ort-related chest pain without evidence of recent deterioration or rest pain within the previous six months. e patients with histories of concomitant in ammatory diseases (such as infection, sepsis, malignancy, liver disease and collagen disease), steroid use or surgery within the month prior to admission, on the basis of the interview, physical examination, biochemistry lab data and urinalysis, were excluded from the study. e study protocol was approved by the Human Research Ethics Committee of the hospital, and informed consent was obtained from each patient.
Laboratory measurements
In all cases, blood was drawn for the measurement of IS, centrifuged and the supernatant was transferred to a separate container before storing. Before coronary angiography, serum creatinine, uric acid and lipid pro les were measured via standard commercial methods as described previously [17] . Renal function was de ned on the basis of previously estimated glomerular ltration rate (eGFR) values, which were calculated according to the extended Modi cation of Diet in Renal Disease (MDRD) formula [18] . Prior to determination of IS, serum samples were deproteinized by adding three parts methanol to one part serum. All analyses were performed using a Waters Acquity Ultra Performance Liquid Chromatography (UPLC) system (Milford, MA, USA) as described previously [12, 19] .
Angiographic De nitions
Coronary angiograms were obtained according to standard techniques and the severity of stenosis was assessed using quantitative coronary angiography. Angiograms were obtained and quantitative coronary angiographic analysis was performed by at least two experienced interventional cardiologists blinded to clinical information and serologic parameters.
e possible scores for severity of stenosis ranged from 0 to 3 diseased vesHsu et al. Indoxyl sulfate and coronary atherosclerosis sels. e possible scores of this index ranged from 0 to 3 diseased vessels. e criterion for 1-, 2-, or 3-vessel disease was ≥50% luminal reduction of the right coronary artery. e stenosis of the le main coronary artery did not exceed 50%.
e modi ed Gensini index is the sum of the total weights for each segment [20] .
Agatston scores were determined using CAC-scoring so ware (SmartScore, GE Healthcare, San Francisco, CA, USA). e Agatston calcium score was obtained by multiplying the area of coronary calci cation by a weighting factor dependent on the peak signal anywhere in the lesion. e scores for individual lesions were added to obtain the Agatston calcium score for the entire coronary tree. e total calcium volume was calculated by multiplying the area of the calci ed lesion (measured in square millimeters) by section thickness.
Statistical analysis
Data normality was analyzed using the Kolmogorov-Smirnov test. Continuous, normally distributed variables were presented as mean ± SD and non-normally distributed variables as median (inter-quartile range). Statistical di erences in variables were compared using unpaired Student's t-tests for normally distributed variables. Categorical variables were recorded as frequencies and/or percentages, and inter-group comparisons were analyzed by chi-square test. Since the distribution of serum IS, and triglycerides were skewed, logarithmically transformed values were used for statistical analysis, with signi cant di erences being determined using unpaired Student's t-tests. Using multiple logistic regression, these variables were assessed for independent associations with the presence of CAD. Association of IS and severity of CAD were analyzed by logistic regression, using the non-diseased vessel group as a reference. For strati ed analysis, the multivariable-adjusted odds ratio (OR) associated with a doubling in severity of coronary artery disease was calculated. Multivariate adjusted ORs are presented with 95% con dence interval (CI). e Spearman correlation analysis was used to examine correlations between serum IS and the values of cardiovascular risk factors. Statistical signicance was accepted if p < 0.05. All of the statistical analyses were performed using the SAS statistical so ware, version 8.2 (SAS Institute; Cary, NC, USA).
Results
Patients' baseline clinical, biochemical and angiographic characteristics are listed in Table 1 . ere was no statistically signicant di erence in serum IS levels between men and women. Patient groups with and without traditional cardiovascular risk factors did not have signi cantly di erent serum IS levels, with one exception: patient groups with and without diabetes showed a signi cant di erence in serum IS levels (data not shown). A statistically signi cant association was observed between age and serum IS concentration (β = 0.327, p <0.0001, n = 191).
Seventy-four patients were categorized as having no CAD, while 117 patients were categorized as having 1-, 2-, or 3-vessel disease (Table 1) . Median serum total IS levels in patients with CAD were signi cantly higher than levels in patients without CAD ( Table 1 ). A statistically signi cant di erence in total IS levels was seen among patients categorized according to the number of diseased vessels (p < 0.05). As expected, CAD subjects were predominantly male, older, smokers, with a higher incidence of hypertension, hyperlipidemia and diabetes mellitus, higher levels of fasting sugar, triglyceride, uric acid and creatinine and higher Gensini scores than those of non-CAD control subjects. CAD subjects also had lower total cholesterol, HDL-C, albumin levels and estimated GFR than those of non-CAD control subjects, while BMI, systolic blood pressure, diastolic blood pressure, triglyceride, LDL-C and total white blood cell count were not signi cantly di erent between the two groups.
Multivariate logistic regression analysis, including traditional cardio-vascular risk factors and biochemical measurements, revealed that body mass index, hypertension, diabetes, HDL-C, uric acid, eGFR and IS were all independently associated with CAD (Table 2) . Moreover, simple and multivariable logistic regression analysis found that serum IS levels were associated with the number of diseased vessels. Multiple logistic regression analysis in fully adjusted odds ratios for number of diseased vessels in the one-vessel, two-vessel and three-vessel patients were 0.351 (95% CI, 0.059 -2.093), 3.011 (95% CI, 1.004 -9.751) and 3.076 (95% CI, 1.138 -8.310), respectively (Table 3) .
Spearman correlation analysis revealed that IS was positively associated with age, Agatston calcium score, volume calcium score, modi ed Gensini score, coronary lesions, coronary disease and Framingham-10 year risk score. In addition, eGFR was negatively correlated with levels of IS (Table 4 and Figure  1A and 1B) .
Discussion
e present study demonstrated for the rst time that serum IS levels were positively and signi cantly correlated with the plaque burden of modi ed Gensini score in patients who underwent rst-time coronary angiography for suspected CAD. Data are expressed as mean ± SD, number (percentage), tested using log-transformed data. CAD, coronary artery mated glomerular ltration rate.
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or median (interquartile y disease; HDL, high-den e range). *: Signi cant di ensity lipoprotein; LDL, l erence was low-density lipoprotein. eGFR, esti-A signi cant and positive correlation was also observed between serum IS concentrations and Agatston calcium score, volume calcium score, coronary lesions and Framingham-10 year risk score. Another nding of our study also showed that patients with angiographically-con rmed CAD had signicantly higher levels of IS compared with patients without CAD. Moreover, serum IS levels were independently associated with the presence and severity of CAD and serum IS was directly and negatively associated with eGFR. Although the biological mechanisms involving IS in the pathogenesis of CAD are not well understood, our previous study suggests that IS plays a crucial role in the in ammatory process and in the development of coronary atherosclerosis [12] . Patients with higher IS levels may, therefore, have greater in ammatory tendency and be more vulnerable to CAD development [12] .
IS was initially believed to be a uremic retention solute resulting from renal function deterioration. e overloading of IS in CKD rats results in glomerular sclerosis and interstitial brosis [7] via aberrant genetic expression of TGF-β1, TIMP-1 and Pro-α1 collagen [21, 22] , as well as complex redox altera- tions [23] . IS also causes endothelial and vascular dysfunction by promoting vascular smooth muscle cell proliferation [15] through activation of platelet-derived growth factor receptors [15] and mitogen-activated protein kinase pathways [10] . Clinically, IS is associated with increased aortic calci cation and vascular sti ness [2] . Another study also demonstrates a gradual, but signi cant, increase in serum IS as the CKD stage worsens and this has been shown to be associated with cardiovascular mortality risk [2] . Interestingly, results on the association between serum IS and coronary atherosclerotic severity, calcium scores and Framingham-10 year risk score are consistent with previous reports of IS association with endothelial damage and cardiovascular risk [2, 9] . spite a signi cant association between high-serum IS and coronary atherosclerosis progression, the mechanisms of how IS promotes disease remain to be elucidated. It has been demonstrated that IS as a pro-in ammatory factor by inducing endothelial dysfunction [8, 9, 24] . Faure et al. have reported that IS induces endothelial damage by increasing the production of human umbilical vein endothelial cell (HUVEC) microparticles and inhibiting HUVEC proliferation and migration [24] . IS synergistically enhances ROS production and PDGFinduced proliferation and migration of VSMCs, which indi- cates that IS stimulates the pathogenesis of atherosclerosis [15] . Regardless of whether or not IS induces free radicals or microparticle production, inhibits endothelial cell proliferation, activates NADPH oxidase, which decreases the antioxidant defense and enhances smooth muscle cell proliferation, these are all major contributors to the pathogenesis of endothelial dysfunction, which is the initial step towards coronary atherosclerosis. ere are some limitations of this study that need to be considered. e cross-sectional design limits the ability to infer a causal relationship between increased serum IS levels and CAD. A single measurement of blood IS does not enable analysis of the relationship over time. Long-term follow-up, to clarify the role of serum IS in association with CAD, is warranted. Moreover, in the in vivo study, whether IS induces CAD is related to endothelial dysfunction (i.e., adhesion molecule enhancement, in ammatory e ects of vessel and oxidative overstress or coagulant activity increase) remains unclear. Further investigation is needed.
In conclusion, elevated IS levels in stable angina subjects are associated with an increase in the number of diseased coronary vessels and plaque burden, as measured by Gensini score and Framingham-10 year risk score. is association indicates that IS is not only a good candidate for a uremic-speci c pathogen but may also play a role in the development and severity of coronary atherosclerosis and future cardio-vascular risk prediction.
